Report cover image

Breast Cancer Core Needle Biopsy Market Growth, Size, Trends Analysis - By Technology, By End-use- Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Published Jul 25, 2025
Length 248 Pages
SKU # SPER20400324

Description

Breast Cancer Core Needle Biopsy Market Introduction and Overview

According to SPER market research, ‘Global Breast Cancer Core Needle Biopsy Market Size- By Technology, By End-use – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Breast Cancer Core Needle Biopsy Market is predicted to reach 1398.03 million by 2034 with a CAGR of 4.86%.
Breast cancer core needle biopsy is a minimally invasive diagnostic method that takes small samples of breast tissue for examination. To recover tissue cores, a hollow needle is placed into the suspicious area, guided by imaging modalities such as ultrasonography, mammography, or MRI. This approach accurately detects malignant cells while providing minimal discomfort and avoiding the need for surgical biopsy.

Restraints: The breast cancer core needle biopsy market faces various challenges that could hamper its growth. One key impediment is the growing demand for less invasive diagnostic methods like as liquid biopsies and micro needle aspiration, which can be more cost-effective. Furthermore, stringent regulatory requirements for product licensing and clinical validation can cause delays in the introduction of new technologies, increasing development costs and limiting market entry for smaller businesses.

Scope of the report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034

Segments covered

By Technology, By End-use

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

Argon Medical Devices, Becton - Dickinson and Company, C.R. Bard, Inc., Cook Medical Incorporated, Encapsule Medical Devices LLC, Ethicon Surgical Technologies, Gallini SRL, Hologic, Inc., Intact Medical Corporation, Leica Biosystems Nussloch GmbH.

By Technology:

Based on the Technology, Global Breast Cancer Core Needle Biopsy Market is segmented as; MRI-based Breast Biopsy, Ultrasound-based Breast Biopsy, Mammography-based Breast Biopsy, CT-based Breast Biopsy, Other Image Based Breast Biopsy.

By End-use:

Based on the End-use: Global Breast Cancer Core Needle Biopsy Market is segmented as; Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes.

By Region:

This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

248 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Breast Cancer Core Needle Biopsy Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Breast Cancer Core Needle Biopsy Market
7. Global Breast Cancer Core Needle Biopsy Market, By Technology (USD Million) 2021-2034
7.1. MRI-based Breast Biopsy
7.2. Ultrasound-based Breast Biopsy
7.3. Mammography-based (Stereotactic) Breast Biopsy
7.4. CT-based Breast Biopsy
7.5. Other Image Based Breast Biopsy
8. Global Breast Cancer Core Needle Biopsy Market, By End-Use (USD Million) 2021-2034
8.1. Hospitals & Diagnostic Laboratories
8.2. Pharmaceutical & Biotechnology Companies
8.3. Academic & Research Institutes
9. Global Breast Cancer Core Needle Biopsy Market, (USD Million) 2021-2034
9.1. Global Breast Cancer Core Needle Biopsy Market Size and Market Share
10. Global Breast Cancer Core Needle Biopsy Market, By Region, (USD Million) 2021-2034
10.1. Asia-Pacific
10.1.1. Australia
10.1.2. China
10.1.3. India
10.1.4. Japan
10.1.5. South Korea
10.1.6. Rest of Asia-Pacific
10.2. Europe
10.2.1. France
10.2.2. Germany
10.2.3. Italy
10.2.4. Spain
10.2.5. United Kingdom
10.2.6. Rest of Europe
10.3. Middle East and Africa
10.3.1. Kingdom of Saudi Arabia
10.3.2. United Arab Emirates
10.3.3. Qatar
10.3.4. South Africa
10.3.5. Egypt
10.3.6. Morocco
10.3.7. Nigeria
10.3.8. Rest of Middle-East and Africa
10.4. North America
10.4.1. Canada
10.4.2. Mexico
10.4.3. United States
10.5. Latin America
10.5.1. Argentina
10.5.2. Brazil
10.5.3. Rest of Latin America
11. Company Profile
11.1. Argon Medical Devices
11.1.1. Company details
11.1.2. Financial outlook
11.1.3. Product summary
11.1.4. Recent developments
11.2. Becton- Dickinson and Company
11.2.1. Company details
11.2.2. Financial outlook
11.2.3. Product summary
11.2.4. Recent developments
11.3. C. R. Bard, Inc.
11.3.1. Company details
11.3.2. Financial outlook
11.3.3. Product summary
11.3.4. Recent developments
11.4. Cook Medical Incorporated
11.4.1. Company details
11.4.2. Financial outlook
11.4.3. Product summary
11.4.4. Recent developments
11.5. Encapsule Medical Devices LLC
11.5.1. Company details
11.5.2. Financial outlook
11.5.3. Product summary
11.5.4. Recent developments
11.6. Ethicon Surgical Technologies
11.6.1. Company details
11.6.2. Financial outlook
11.6.3. Product summary
11.6.4. Recent developments
11.7. Gallini SRL
11.7.1. Company details
11.7.2. Financial outlook
11.7.3. Product summary
11.7.4. Recent developments
11.8. Hologic, Inc.
11.8.1. Company details
11.8.2. Financial outlook
11.8.3. Product summary
11.8.4. Recent developments
11.9. Intact Medical Corporation
11.9.1. Company details
11.9.2. Financial outlook
11.9.3. Product summary
11.9.4. Recent developments
11.10. Leica Biosystems Nuss Loch GmbH
11.10.1. Company details
11.10.2. Financial outlook
11.10.3. Product summary
11.10.4. Recent developments
11.11. Others
12. Conclusion
13. List of Abbreviations
14. Reference Links
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.